This week’s newest patent applications are from Saras-3D, Abbott, Novartis, Medtronic, Roche, Boston Scientific, Merck, Mastercard, IBM, Microsoft, Apple, and Intel.
Saras-3D Pursues a Patent on a 2D/3D Conversion Interface Component
U.S. patent application, US20210377514, discloses a user interface module for converting a standard two-dimensional (2D) display device into an interactive three-dimensional (3D) display device. The module overrides the video processing capabilities associated with the conventional 2D display, re-formats an incoming 3D video stream into a version compatible with the 2D display while preserving the 3D type of presentation. The figure below depicts an exemplary setting with the 2D/3D conversion interface.
Abbott Wants to Patent Analyte Sensors for Detecting Inhibitors of Diaphorase
U.S. patent application, US20210369155, relates to analyte sensors utilizing multiple enzymes for the detection of one or more analytes. The sensors include an electron transfer agent and an enzyme system with diaphorase and NAD-dependent dehydrogenase to detect inhibitors of diaphorase. The figure below illustrates the sensing system incorporating the analyte sensor.
Novartis Seeks a Patent for Adeno-Associated Virus Virions with Variant Capsids
U.S. patent application, US20210371879, relates to recombinant adeno-associated virus (rAAV) virions that are useful for the delivery of gene products to a retinal cell. The rAAV virion includes a variant capsid protein and a heterologous nucleic acid containing one or more nucleotide sequences encoding one or more heterologous gene products.
Medtronic Pursues a Patent on an Apparatus for Creating a Chronically Stable Atrial Shunt
U.S. patent application, US20210369321, discloses a method of creating a shunt between a right atrium and a left atrium of a mammalian heart. The method includes puncturing the atrial septum, advancing an ablation device having a balloon partially through the opening, inflating the balloon to thermally isolate the atrial septum from the blood, and delivering ablation energy to the atrial septum. The figure below shows the procedure for creating an atrial shunt with pulse-field ablation energy.
Roche Eyes a Patent for Methods for Forming a Nanopore in a Lipid Bilayer
U.S. patent application, US20210372987, discloses a method of forming a nanopore in a lipid bilayer. The method includes depositing a nanopore forming solution over a lipid bilayer and then applying a voltage stimulus waveform across the membrane to preferentially insert a nanopore into the membrane through an active mechanism. The figure below illustrates a nanopore device comprising a nanopore-containing lipid bilayer.
Boston Scientific Files a Patent for Methods for Producing Cardiomyocyte Cells
U.S. patent application, US20210370057, discloses a method for stimulating the growth of new contractile heart muscle cells and cardiac tissue. The method includes implanting a biocompatible polymer substrate within a heart to form trabecular fibers extending between the endocardium and removing the trabecular fibers containing the cardiomyocyte cells from the heart. The figure below illustrates the implantation of a substrate for stimulating the growth of new cardiomyocyte cells.
Merck Aims to Patent a Combination Therapy Utilizing DNA Alkylating Agents and ATR Inhibitors
U.S. patent application, US20210369705, relates to synergistic combinations of DNA-alkylating ADCs (Antibody-Drug Conjugates) that bears duocarmycin and ATR (Ataxia Telangiectasia and RAD3-related) inhibitors to treat cancer. The figure below shows the chemical structures of the duocarmycin-variants studied in the ADC format.
Mastercard Seeks to Patent a Secure Presentation of Transaction Card Data for Numberless Transaction Cards
U.S. patent application, US20210374719, discloses a method for quickly and securely presenting transaction data of a numberless transaction card on a user interface The method includes pairing a user device and the transaction card based on a pairing identifier, validating the pairing between the user device and the transaction card, communicating the transaction card data to the user device upon validation, and presenting the communicated transaction data on the user interface.
IBM Aims to Patent a Smart Contact Lens with Adjustable Light Transmittance
U.S. patent application, US20210375230, discloses a method for adjusting the transmittance of a smart contact lens. The method includes determining historic eye data and a current eye condition of a user and adjusting the transmittance of the smart contact lens worn by the user based on the determined current eye condition. The figure below illustrates the exemplary operation of the smart contact lens.
Microsoft Seeks a Patent for an Automatic Notification of Data Changes
U.S. patent application, US20210377203, describes a method for providing automatic notification on data changes. The method includes determining an analysis preference of a target user based on the information collected from a dataset, a data dashboard, or a data report, detecting an alert based on a variety of critical data changes in an updated dataset, and providing a notification to the user based on the alert. The figure below illustrates the environment for automatic notification of data changes.
Apple Aims to Patent an Augmented Reality Interface for Facilitating the Identification of an Arriving Vehicle or a Passenger
U.S. patent application, US20210374407, discloses an augmented reality interface for facilitating the identification of an arriving vehicle and/or a passenger. A passenger scans a scenery using a mobile device to determine and display an indication related to the vehicle location. Similarly, a driver in the vehicle scans the scenery using his mobile device to determine and display an indication related to the passenger’s location. The figure shows the mobile device depicting the identification of the passenger using augmented reality.
Intel Aims to Patent a System for Monitoring and Scoring Passenger Attention
U.S. patent application, US20210370954, discloses a system for monitoring observed attributes such as a gaze or a head track of the passenger and determining a field of view (FOV) of the passenger. The system determines a focus point of the passenger within the FOV and records an attention score for a sign (e.g., a road sign, a billboard, etc.) within the FOV of the passenger based on the duration of time during which the sign is within the FOV. The figure below illustrates how passengers in a vehicle pay attention to various objects outside the vehicle.